Ullman Medical

About

Ullman Medical has identified and developed a novel botanical extract that demonstrated positive human clinical data in treating psoriasis. Pre-clinical evidence also showed non-toxic, anti-angiogenesis properties that may be effective in the treatment of eye diseases, arthritis, and certain cancers. The companys objective is the commercialization of this plant-based compound for the topical treatment of psoriasis and development of a therapeutic platform for the treatment of numerous immune-deficient diseases. Psoriasis remains a chronic skin disease with few safe, effective topical treatments.

Facts

Team (1)

News mentions (1)

1. Jan 31, 2018 — stks.freshpatents.com: Article